OpiSafe is a clinical data platform for opioid prescribing and public health response, covering pain management, addiction treatment, pharmacy automation, and overdose rescue. Its core value is not general-purpose enterprise collaboration, but bringing PDMP/PMP queries, toxicology results, patient-reported outcomes, and risk scoring into the clinical decision-making workflow, helping prescribers identify misuse risks faster and generate compliance reports.
In prescribing and pain-management settings, the platform supports Morphine Equivalent dose ranges, pain and function scores, opioid misuse risk scores, comorbidity tracking, automated PDMP checks, urine/lab result management, patient/prescriber agreements, and monitoring of anomalous events. For MAT use cases, it adds withdrawal-symptom and behavioral-health scoring. The pharmacy version emphasizes bulk PDMP queries, a rules engine, and integration with dispensing systems. OpiRescue is aimed at first responders, providing overdose recognition, naloxone reversal guidance, mobile/desktop reporting, geographic data, and agency-level analytics. The source text also mentions an EHR Marketplace, major EHR integrations, a PDMP API, and interoperability APIs, but does not disclose technical documentation details.
The source text does not provide plans, quotes, deployment fees, or contract terms for OpiSafe or OpiRescue HQ. The only clear point is that the OpiRescue mobile/Web tool is free. The platform claims it can help reduce medical liability insurance costs and lower claims inquiries and denials through reimbursement-support reporting, but these are indirect economic benefits and cannot substitute for clear pricing information.
Its strengths are its deep focus on a vertical use case and its closed-loop coverage of the opioid lifecycle, from prescribing and monitoring to pharmacy workflows and emergency response. The claim that PDMP queries can be reduced from several minutes to around 30 seconds suggests meaningful automation value. EHR and dispensing-system embedding can also help reduce context switching for clinical staff. Its weaknesses are insufficient security and compliance disclosure: common healthcare SaaS procurement details such as HIPAA, SOC 2, permissions, audit logs, and encryption are not visible. Pricing is completely opaque. The product is also highly dependent on the U.S. PDMP, CDC/QPP, and SAMHSA context, limiting its applicability internationally.
It is better suited to U.S. pain clinics, MAT addiction-treatment providers, high-volume pharmacies, emergency response departments, and public health or government programs. Even if users in China can access the website, practical adoption would be constrained by differences in local regulation, prescription-drug monitoring systems, payment models, and medical information systems. In practice, alternatives should first be sought among domestic electronic medical record, pharmacy management, prescription review, and public health reporting systems. The source text does not provide China access status, so it should be considered unknown.
β This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on opisafe.com official site.
opisafe.com is an United States SaaS Tools provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach opisafe.com directly.